MedTrace Logo

Validation of the C-mo System - Cough Monitoring

NCT05989698 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom.

The main questions it aims to answer are:

1. Can C-mo System detect cough events? (automatic cough detection)
2. Can C-mo System characterise cough events? (calculation of cough intensity, identification of cough type and presence of wheeze in detected coughs)

Participants will be asked to:

* Wear the C-mo Wearable device for 24 hours (1 day);
* Complete a diary with relevant activities throughout the monitoring period;
* Fill-out questionnaires related to coughing frequency and intensity, usability of the device, and impact of cough on quality of life.

Conditions

Interventions

DEVICE

C-mo System

Patients will use C-mo System for a period of 24h, to assess cough characteristics.

Sponsors & Collaborators

  • Universidade Nova de Lisboa

    collaborator OTHER

  • Cough Monitoring Medical Solutions

    lead INDUSTRY

Principal Investigators

  • Nuno M Neuparth, PhD · NOVA Medical School | Faculdade de Ciências Médicas da Universidade Nova de Lisboa

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-11
Primary Completion
2026-06-30
Completion
2026-09-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05989698 on ClinicalTrials.gov